Dr. Chase Escott

Radiation OncologyMale6+ years of experience
Dr. Chase Escott is a radiation oncologist in Murfreesboro, Tennessee. He graduated from Geisel School of Medicine at Dartmouth in 2016 and has been in practice for 6+ years.
LocationEducationRatingsAbout MeHospitalsConditions TreatedSpecialtySimilar

Location

Dr. Chase Escott
1840 Medical Ctr Pkwy
Suite 102
Murfreesboro, Tennessee 37129

Education

Medical school

Dr. Escott attended Geisel School of Medicine at Dartmouth and graduated in 2016 (6 years ago). Geisel School of Medicine at Dartmouth is ranked #47 number in the "Best Medical Schools" by U.S. News.

About Me

Dr. Escott works at Tennessee Oncology PLLC, which has 197 other health providers.

Primary specialty
Radiation Oncology
Years of experience
6+ years
Gender
Male
NPI
1659735298

Hospital Affiliations

Dr. Escott is affiliated with the following hospitals.

Saint Thomas Rutherford Hospital
Tristar Summit Medical Center

Conditions Treated

As a radiation oncology, Dr. Escott may see patients with the following conditions. Please check with Dr. Escott what conditions he treats. Dr. Escott may treat additional conditions not listed.

  • Acoustic neuroma
  • Acute lymphocytic leukemia
  • Adnexal tumors
  • Adrenal cancer
  • Ameloblastoma
  • Ampullary cancer
  • Anal cancer
  • Bladder cancer
  • Bone cancer
  • Brain cancer
Show more +

Specialties

Dr. Escott is a radiation oncologist.

Radiation Oncology

A radiation oncologist is a specialist physician who uses ionizing radiation (such as megavoltage X-rays or radionuclides) in the treatment of cancer. Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. A radiation oncologist may also use radiation to treat some benign diseases, including benign tumors.